MetaCap

Jaguar Health Insider Trades

NASDAQ: JAGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

4.79+0.26 (+5.74%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Jaguar Health insider activity

Over the last 12 months, Jaguar Health insiders reported 9 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows MICEK JOHN (Director) reporting a transaction in 7,377 shares on Dec 11, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put JAGX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

JAGX insider transactions

Jaguar Health insider transactions
DateInsiderTypeSharesValueFiling
Dec 11, 2025Lizak Carol R.Chief Financial OfficerAward11,740—Form 4
Dec 11, 2025Jayasuriya AnulaDirectorAward5,870—Form 4
Dec 11, 2025Siegel Jonathan B.DirectorAward7,377—Form 4
Dec 11, 2025BOCHNOWSKI JAMES JDirectorAward6,363—Form 4
Dec 11, 2025Chaturvedi Pravin RChief Scientific OfficerAward11,740—Form 4
Dec 11, 2025Wolin Jonathan S.See RemarksAward11,740—Form 4
Dec 11, 2025CONTE LISA ASee RemarksAward28,592—Form 4
Dec 11, 2025King Steven R.See RemarksAward11,740—Form 4
Dec 11, 2025MICEK JOHNDirectorAward7,377—Form 4
May 17, 2025King Steven R.See RemarksOption exercise1—Form 4
May 17, 2025CONTE LISA ACEO and PresidentOption exercise2—Form 4
Oct 8, 2024King Steven R.See RemarksAward4,922—Form 4
Oct 8, 2024Chaturvedi Pravin RChief Scientific OfficerAward4,922—Form 4
Oct 8, 2024CONTE LISA ASee RemarksAward16,503—Form 4
Oct 8, 2024Wolin Jonathan S.See RemarksAward4,922—Form 4
Oct 8, 2024Lizak Carol R.Chief Financial OfficerAward4,280—Form 4
May 17, 2024CONTE LISA ACEO and PresidentOption exercise2,695—Form 4
May 17, 2024King Steven R.See RemarksOption exercise612—Form 4
May 17, 2024Lizak Carol R.Chief Financial OfficerOption exercise431—Form 4
May 17, 2024Wolin Jonathan S.Chief of Staff, CCO & GCOption exercise871—Form 4
May 17, 2024Chaturvedi Pravin RChief Scientific OfficerOption exercise871—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related